\n\n\n\n\t\t\n\t\t\tSinexus\n\t\t\thttp://www.sinexusinc.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tSinexus, Inc. is a medical device company that is pioneering novel therapies for Ear, Nose & Throat (ENT) physicians to utilize in providing improved treatment for their patients. Our initial product...More»
\n\t\t\tSinexus, Inc. is a medical device company that is pioneering novel therapies for Ear, Nose & Throat (ENT) physicians to utilize in providing improved treatment for their patients. Our initial product is a therapeutic device for patients with Chronic Sinusitis, one of the most common chronic conditions affecting one out of seven adults in the United States. Chronic Sinusitis causes debilitating symptoms and has a greater impact on quality of life than congestive heart failure or chronic back pain. Through a combination of internal talent, plus input from leading physicians, Sinexus plans to continue developing novel new products for the ENT community from the application of its proprietary platform technology.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tPalo Alto, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tsinus,\n\t\t\t\tchornic sinusitis,\n\t\t\t\tnose,\n\t\t\t\tENT,\n\t\t\t\tsinexus,\n\t\t\t\tear,\n\t\t\t\tsurgery,\n\t\t\t\tthrouat\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $20M (06/04/2008)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tKleiner Perkins Caufield & Byers,\n\t\t\t\t\t\n\t\tMontreux Equity Partners,\n\t\t\t\t\t\n\t\tPTV Sciences,\n\t\t\t\t\t\n\t\tU.S. Venture Partners,\n\t\t\t\t\t\n\t\tDURECT\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tEntellus Medical\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tAcclarent,\n\t\t\t\t\tEntellus Medical,\n\t\t\t\t\tBlue Chip Surgical Center Partners\n\t\t\t\t
\n\t\t\t